Literature DB >> 3229281

Benzyl alcohol metabolism and elimination in neonates.

M LeBel1, L Ferron, M Masson, J Pichette, C Carrier.   

Abstract

Reports on fatal benzyl alcohol poisoning in premature neonates implied that the toxicity may be due to larger doses per kilogram than for adults. It has been postulated that the load of benzoic acid (metabolite of benzyl alcohol) may exceed the capacity of the immature liver or kidney for detoxification through glycine conjugation to form hippuric acid. To test this hypothesis, 14 term and 9 preterm neonates receiving loading doses of phenobarbital containing benzyl alcohol were studied. Urine and serum benzoic and hippuric acid levels were measured by GC and HPLC methods, respectively. There was greater accumulation of benzoic acid in the serum of preterm compared to the term neonates which was reflected in higher normalized peak levels (2130.6 vs. 237.8 kg/l, p less than 0.001) and larger normalized AUCIV (1,253.2 vs. 483.0 kg.h/l, p less than 0.01). Furthermore, larger percentages of benzyl alcohol doses were found in urine as benzoic acid in preterm babies, while less hippuric acid appeared in their urine than term newborns. These results indicate that hippuric acid formation is deficient in preterm neonates. Although we did not encounter in our patients the specific toxic signs described as part of the benzyl alcohol toxicity syndrome, we cannot directly answer the issue of safety of 'low doses' of benzyl alcohol as found in some medications administered to neonates. This study confirms the immaturity of the benzoic acid detoxification process in premature newborns.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3229281     DOI: 10.1159/000457714

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  9 in total

Review 1.  Iatrogenic environmental hazards in the neonatal intensive care unit.

Authors:  Thomas T Lai; Cynthia F Bearer
Journal:  Clin Perinatol       Date:  2008-03       Impact factor: 3.430

Review 2.  Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients.

Authors:  Hannu Kokki
Journal:  Paediatr Drugs       Date:  2010-10-01       Impact factor: 3.022

3.  Sulfation of benzyl alcohol by the human cytosolic sulfotransferases (SULTs): a systematic analysis.

Authors:  Lingtian Zhang; Katsuhisa Kurogi; Ming-Yih Liu; Alaina M Schnapp; Frederick E Williams; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  J Appl Toxicol       Date:  2015-12-11       Impact factor: 3.446

4.  Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.

Authors:  Hudson C Polonini; Sharlene L Silva; Thalyta R de Almeida; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-03-24

Review 5.  The safety evaluation of food flavouring substances: the role of metabolic studies.

Authors:  Robert L Smith; Samuel M Cohen; Shoji Fukushima; Nigel J Gooderham; Stephen S Hecht; F Peter Guengerich; Ivonne M C M Rietjens; Maria Bastaki; Christie L Harman; Margaret M McGowen; Sean V Taylor
Journal:  Toxicol Res (Camb)       Date:  2018-03-28       Impact factor: 3.524

6.  Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.

Authors:  Georgi Nellis; Tuuli Metsvaht; Heili Varendi; Jana Lass; Jennifer Duncan; Anthony J Nunn; Mark A Turner; Irja Lutsar
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

7.  Comparison of two alternative study designs in assessment of medicines utilisation in neonates.

Authors:  Georgi Nellis; Irja Lutsar; Heili Varendi; Karolin Toompere; Mark A Turner; Jennifer Duncan; Tuuli Metsvaht
Journal:  BMC Med Res Methodol       Date:  2014-07-16       Impact factor: 4.615

8.  Excipient exposure in very low birth weight preterm neonates.

Authors:  T O Akinmboni; N L Davis; A J Falck; C F Bearer; S M Mooney
Journal:  J Perinatol       Date:  2017-11-02       Impact factor: 2.521

9.  Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered.

Authors:  Kristine Svinning Valeur; Helle Holst; Karel Allegaert
Journal:  Pharmaceut Med       Date:  2018-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.